Fig. 2

Study execution scheme. AP, Artemisinin-piperaquine; 2-MDA, two rounds of MDA; 3-MDA, three rounds of MDA; MDA, mass drug administration
Study execution scheme. AP, Artemisinin-piperaquine; 2-MDA, two rounds of MDA; 3-MDA, three rounds of MDA; MDA, mass drug administration